Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

ASP0028 in combination with suboptimal-dose of tacrolimus in Cynomolgus monkey renal transplantation model.

Dun H, Song L, Ma A, Hu Y, Zeng L, Bai J, Zhang G, Zhang L, Koide K, Okada Y, Hanaoka K, Yamamoto R, Hirose J, Morokata T, Daloze P, Chen H.

Transpl Immunol. 2017 Feb;40:57-65. doi: 10.1016/j.trim.2017.01.002. Epub 2017 Jan 7.

PMID:
28077266
2.

ASP2409, A Next-Generation CTLA4-Ig, Versus Belatacept in Renal Allograft Survival in Cynomolgus Monkeys.

Song L, Ma A, Dun H, Hu Y, Fujii Y, Kinugasa F, Oshima S, Higashi Y, Daloze P, Chen H.

Am J Transplant. 2017 Mar;17(3):635-645. doi: 10.1111/ajt.14039. Epub 2016 Oct 20.

3.

Effects of ASKP1240 combined with tacrolimus or mycophenolate mofetil on renal allograft survival in Cynomolgus monkeys.

Song L, Ma A, Dun H, Hu Y, Zeng L, Bai J, Zhang G, Kinugasa F, Sudo Y, Miyao Y, Okimura K, Miura T, Daloze P, Chen H.

Transplantation. 2014 Aug 15;98(3):267-76. doi: 10.1097/TP.0000000000000236.

4.

Pharmacokinetics and pharmacodynamics of ASKP1240, a fully human anti-CD40 antibody, in normal and renal transplanted Cynomolgus monkeys.

Ma A, Dun H, Song L, Hu Y, Zeng L, Bai J, Zhang G, Kinugasa F, Miyao Y, Sakuma S, Okimura K, Kasai N, Daloze P, Chen H.

Transplantation. 2014 Feb 27;97(4):397-404. doi: 10.1097/01.TP.0000440951.29757.bd.

5.

Reconstruction of cartilage with clonal mesenchymal stem cell-acellular dermal matrix in cartilage defect model in nonhuman primates.

Ma A, Jiang L, Song L, Hu Y, Dun H, Daloze P, Yu Y, Jiang J, Zafarullah M, Chen H.

Int Immunopharmacol. 2013 Jul;16(3):399-408. doi: 10.1016/j.intimp.2013.02.005. Epub 2013 Mar 13.

PMID:
23499511
6.

Cartilage regeneration by selected chondrogenic clonal mesenchymal stem cells in the collagenase-induced monkey osteoarthritis model.

Jiang L, Ma A, Song L, Hu Y, Dun H, Daloze P, Yu Y, Jiang J, Zafarullah M, Chen H.

J Tissue Eng Regen Med. 2014 Nov;8(11):896-905. doi: 10.1002/term.1676. Epub 2013 Jan 21.

PMID:
23335439
7.

Adoptive transfer of CD4+CD25+ regulatory cells combined with low-dose sirolimus and anti-thymocyte globulin delays acute rejection of renal allografts in Cynomolgus monkeys.

Ma A, Qi S, Song L, Hu Y, Dun H, Massicotte E, Dupuis M, Daloze P, Chen H.

Int Immunopharmacol. 2011 May;11(5):618-29. doi: 10.1016/j.intimp.2010.11.001. Epub 2010 Nov 20.

PMID:
21094689
8.

Surgical complications in kidney transplantation in nonhuman primates.

Song L, Qi S, Dun H, Hu Y, Ma A, Yu G, Xiong Z, Zhu S, Wang X, Xu D, Li G, Shang Y, Kinugasa F, Sudo Y, Bai J, Zeng L, Daloze P, Chen H.

Microsurgery. 2010 May;30(4):327-31. doi: 10.1002/micr.20740.

PMID:
20049911
9.

Conversion from calcineurin inhibitors to sirolimus in kidney transplant recipients: a retrospective cohort study.

Cardinal H, Froidure A, Dandavino R, Daloze P, Hébert MJ, Colette S, Boucher A.

Transplant Proc. 2009 Oct;41(8):3308-10. doi: 10.1016/j.transproceed.2009.08.049.

PMID:
19857737
10.

Acute rejection in low-toxicity regimens: clinical impact and risk factors in the Symphony study.

Frei U, Daloze P, Vítko S, Klempnauer J, Reyes-Acevedo R, Titiz I, Fricke L, Bernasconi C, Ekberg H.

Clin Transplant. 2010 Jul-Aug;24(4):500-9. doi: 10.1111/j.1399-0012.2009.01093.x.

PMID:
19758267
11.

Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation.

Ekberg H, Bernasconi C, Tedesco-Silva H, Vítko S, Hugo C, Demirbas A, Acevedo RR, Grinyó J, Frei U, Vanrenterghem Y, Daloze P, Halloran P.

Am J Transplant. 2009 Aug;9(8):1876-85. doi: 10.1111/j.1600-6143.2009.02726.x. Epub 2009 Jun 26.

12.

Combined therapy of CD4(+)CD25(+) regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice.

Ma A, Qi S, Wang Z, Massicotte E, Dupuis M, Daloze P, Chen H.

Int Immunopharmacol. 2009 May;9(5):553-63. doi: 10.1016/j.intimp.2009.01.033. Epub 2009 Feb 8.

PMID:
19539558
13.

Dysfunction of IL-10-producing type 1 regulatory T cells and CD4(+)CD25(+) regulatory T cells in a mimic model of human multiple sclerosis in Cynomolgus monkeys.

Ma A, Xiong Z, Hu Y, Qi S, Song L, Dun H, Zhang L, Lou D, Yang P, Zhao Z, Wang X, Zhang D, Daloze P, Chen H.

Int Immunopharmacol. 2009 May;9(5):599-608. doi: 10.1016/j.intimp.2009.01.034. Epub 2009 Feb 10.

PMID:
19539557
14.

The challenge of achieving target drug concentrations in clinical trials: experience from the Symphony study.

Ekberg H, Mamelok RD, Pearson TC, Vincenti F, Tedesco-Silva H, Daloze P.

Transplantation. 2009 May 15;87(9):1360-6. doi: 10.1097/TP.0b013e3181a23cb2.

PMID:
19424036
15.

Cryopreservation of vascularized ovary: an evaluation of histology and function in rats.

Qi S, Ma A, Xu D, Daloze P, Chen H.

Microsurgery. 2008;28(5):380-6. doi: 10.1002/micr.20516.

PMID:
18561270
16.

Reduced exposure to calcineurin inhibitors in renal transplantation.

Ekberg H, Tedesco-Silva H, Demirbas A, Vítko S, Nashan B, Gürkan A, Margreiter R, Hugo C, Grinyó JM, Frei U, Vanrenterghem Y, Daloze P, Halloran PF; ELITE-Symphony Study.

N Engl J Med. 2007 Dec 20;357(25):2562-75.

17.

Effect of Baohuoside-1 aglycone and tacrolimus monotherapy and combination therapy on prevention of acute heart allograft rejection in the rat.

Qi S, Zhao H, Ma A, Liu L, Wang X, Xu D, Lin G, Tamura K, Jiang H, Daloze P, Chen H.

Microsurgery. 2007;27(4):268-70.

PMID:
17477431
18.

Effect of a novel inducible nitric oxide synthase inhibitor, FR260330, in prevention of renal ischemia/reperfusion injury in vervet monkeys.

Qi S, Xu D, Ma A, Zhang X, Chida N, Sudo Y, Tamura K, Daloze P, Chen H.

Transplantation. 2006 Feb 27;81(4):627-31.

PMID:
16495814
19.

Renal cell carcinoma in kidney allografts: a case series from a single center.

Barama A, St-Louis G, Nicolet V, Hadjeres R, Daloze P.

Am J Transplant. 2005 Dec;5(12):3015-8.

20.

Baohuoside-1 inhibits activated T cell proliferation at G(1)-S phase transition.

Ma A, Qi S, Xu D, Daloze P, Chen H.

Transpl Immunol. 2005 Oct;15(1):55-62. Epub 2005 Jun 16.

PMID:
16223673
21.

Effect of a novel inducible nitric oxide synthase inhibitor in prevention of rat chronic aortic rejections.

Ouyang J, Xu D, Zhang X, Qi S, Ma A, Jiang W, Chida N, Sudo Y, Tamura K, Daloze P, Chen H.

Transplantation. 2005 May 27;79(10):1386-92.

PMID:
15912108
22.
23.

Baohuoside-1, a novel immunosuppressive molecule, inhibits lymphocyte activation in vitro and in vivo.

Ma A, Qi S, Xu D, Zhang X, Daloze P, Chen H.

Transplantation. 2004 Sep 27;78(6):831-8.

PMID:
15385801
24.

Total cholesterol correlates with cyclosporine C2 levels in kidney transplant recipients under maintenance immunosuppression.

Cardinal H, Barama AA, Fradet V, Lallier M, Lévesque R, St Louis G, Hébert MJ, Girardin C, Pâquet M, Daloze P.

Transplant Proc. 2004 Mar;36(2 Suppl):448S-450S.

PMID:
15041384
25.

Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal.

Kreis H, Oberbauer R, Campistol JM, Mathew T, Daloze P, Schena FP, Burke JT, Brault Y, Gioud-Paquet M, Scarola JA, Neylan JF; Rapamune Maintenance Regimen Trial.

J Am Soc Nephrol. 2004 Mar;15(3):809-17.

26.

Synergistic effects of RAD and Neoral in inhibition of host-vs.-graft and graft-vs.-host immune responses in rat small-bowel transplantation.

Johnson S, Qi S, Xu D, Jolicoeur M, Liu D, Barama A, Busque S, Smeesters C, Daloze P, Chen H.

Microsurgery. 2003;23(5):476-82.

PMID:
14558006
27.

Modulation of matrix gelatinases and metalloproteinase-activating process in acute kidney rejection.

Laplante A, Liu D, Demeule M, Annabi B, Murphy GF, Daloze P, Chen H, Béliveau R.

Transpl Int. 2003 Apr;16(4):262-9. Epub 2003 Feb 13.

PMID:
12730807
28.

Significant prolongation of renal allograft survival by delayed combination therapy of FK778 with tacrolimus in nonhuman primates.

Qi S, Zhu S, Xu D, Wang X, Ouyang J, Jiang W, Vu MD, Bilolo K, Ma A, Johnson S, Daloze P, Bekersky I, Fitzsimmons WE, Chen H.

Transplantation. 2003 Apr 27;75(8):1124-8.

PMID:
12717189
29.

Combination therapy of mycophenolate mofetil and rapamycin in prevention of chronic renal allograft rejection in the rat.

Jolicoeur EM, Qi S, Xu D, Dumont L, Daloze P, Chen H.

Transplantation. 2003 Jan 15;75(1):54-9.

PMID:
12544871
30.

Low-dose tacrolimus, trough-monitored mycophenolate mofetil, and planned steroid withdrawal for cadaveric kidney transplantation: a single center experience.

Beaunoyer M, Busque S, St-Louis G, Smeesters C, Pâquet M, Lallier M, Fugère J, Girardin C, Hébert MJ, Daloze P.

Transplant Proc. 2002 Aug;34(5):1694-5. No abstract available.

PMID:
12176540
31.

Compromised kidney graft rejection response in Vervet monkeys after withdrawal of immunosuppressants tacrolimus and sirolimus.

Chen H, Peng J, Luo H, Loubeau M, Wan X, Xu D, Qi S, Vu MD, Daloze P, Fitzsimmons WE, Bekersky I, Peets J, Sehgal SN, Wu J.

Transplantation. 2000 Apr 27;69(8):1555-61.

PMID:
10836361
32.

Effect of tacrolimus (FK506) and sirolimus (rapamycin) mono- and combination therapy in prolongation of renal allograft survival in the monkey.

Qi S, Xu D, Peng J, Vu MD, Wu J, Bekersky I, Fitzsimmons WE, Peets J, Sehgal S, Daloze P, Chen H.

Transplantation. 2000 Apr 15;69(7):1275-83.

PMID:
10798741
33.

Blocking of CD44-hyaluronic acid interaction prolongs rat allograft survival.

Zhang W, Gao L, Qi S, Liu D, Xu D, Peng J, Daloze P, Chen H, Buelow R.

Transplantation. 2000 Feb 27;69(4):665-7.

PMID:
10708127
34.

[Hypertrichosis and gingival hypertrophy regression in renal transplants following the substitution of cyclosporin by tacrolimus].

Busque S, Demers P, Saint-Louis G, Boily JG, Tousignant J, Lemieux F, Martin G, Smeesters C, Corman J, Daloze P.

Ann Chir. 1999;53(8):687-9. French.

PMID:
10584376
35.

Immunomodulating effects of second-generation calcium channel blockers on experimental heart transplantation.

Lapointe N, Chen H, Qi S, Xu D, Daloze P, Dumont L.

Eur Surg Res. 1999;31(3):259-66.

PMID:
10352354
36.
37.

Combined effect of rapamycin and FK 506 in prolongation of small bowel graft survival in the mouse.

Chen H, Qi S, Xu D, Fitzsimmons WE, Bekersky I, Sehgal SN, Daloze P.

Transplant Proc. 1998 Sep;30(6):2579-81. No abstract available.

PMID:
9745497
38.

Mycoplasma fermentans DNA is infrequently detected in urine specimens from renal transplant recipients.

Coutlée F, Saint-Louis G, Voyer H, Daloze P, Ghadirian P.

Mol Cell Probes. 1998 Aug;12(4):201-6.

PMID:
9727195
39.
40.

Conversion from Neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis.

Busque S, Demers P, St-Louis G, Boily JG, Tousignant J, Lemieux F, Smeesters C, Corman J, Daloze P.

Transplant Proc. 1998 Jun;30(4):1247-8. No abstract available.

PMID:
9636507
41.

Mycophenolate mofetil's effect on accelerated heart allograft rejection and rejection markers in the rat.

Chen H, Qi S, Xu D, Wu J, Busque S, Daloze P.

Transplant Proc. 1998 Jun;30(4):1049-50. No abstract available.

PMID:
9636424
42.

FK 506 and rapamycin in combination are not antagonistic but produce extended small bowel graft survival in the mouse.

Chen H, Qi S, Xu D, Vu DM, Fitzsimmons WE, Bekersky I, Peets J, Sehgal SN, Daloze P.

Transplant Proc. 1998 Jun;30(4):1039-41. No abstract available.

PMID:
9636419
43.

Rapamycin's effect on vasomotion in the rat.

Milliard S, Silva A, Blaise G, Chen H, Xu D, Qi S, Daloze P.

Transplant Proc. 1998 Jun;30(4):1036-8. No abstract available.

PMID:
9636418
44.

Safety and tolerability of cyclosporine and cyclosporine microemulsion during 18 months of follow-up in stable renal transplant recipients: a report of the Canadian Neoral Renal Study Group.

Cole E, Keown P, Landsberg D, Halloran P, Shoker A, Rush D, Jeffrey J, Russell D, Stiller C, Muirhead N, Paul L, Zaltzman J, Loertscher R, Daloze P, Dandavino R, Boucher A, Handa P, Lawen J, Belitsky P, Parfrey P, Tan A, Hendricks L.

Transplantation. 1998 Feb 27;65(4):505-10.

PMID:
9500624
45.

Tacrolimus (FK506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat.

Vu MD, Qi S, Xu D, Wu J, Fitzsimmons WE, Sehgal SN, Dumont L, Busque S, Daloze P, Chen H.

Transplantation. 1997 Dec 27;64(12):1853-6.

PMID:
9422432
46.

Bilomas developing after laparoscopic biliary surgery: percutaneous management with embolization of biliary leaks.

Oliva VL, Nicolet V, Soulez G, Falardeau M, Daloze P, Abou Jaoude M, Carignan L.

J Vasc Interv Radiol. 1997 May-Jun;8(3):469-73. No abstract available.

PMID:
9152924
47.

Induction of long-term small bowel graft survival by low-dose immunosuppression in tolerized recipient rats.

Chen H, Xu D, Qi S, Busque S, Tan A, Daloze P.

Transplant Proc. 1997 Feb-Mar;29(1-2):697-8. No abstract available.

PMID:
9123486
48.

A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients. Report of the Canadian Neoral Renal Transplantation Study Group.

Keown P, Landsberg D, Halloran P, Shoker A, Rush D, Jeffery J, Russell D, Stiller C, Muirhead N, Cole E, Paul L, Zaltzman J, Loertscher R, Daloze P, Dandavino R, Boucher A, Handa P, Lawen J, Belitsky P, Parfrey P.

Transplantation. 1996 Dec 27;62(12):1744-52.

PMID:
8990355
50.

Immunosuppressive effects of the cyclosporin derivative SDZ IMM 125 on kidney allograft in the dog and small bowel and pancreas allografts in the rat.

Chen H, Qi S, Xu D, Bergeron E, Wu J, Beauregard-Zollinger L, Tan A, Daloze P.

Clin Immunol Immunopathol. 1996 Jul;80(1):76-81.

PMID:
8674242

Supplemental Content

Loading ...
Support Center